患有CDK12突变的前列腺癌的阴茎转移:一个病例报告和文献综述
Qi Xiang1,2, Yanwu Wang2, Bin Yao2
1Department of Urology, The Fifth Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510900, P.R. China.
Oncology letters
|February 26, 2026
概括
由前列腺癌引起的阴茎转移是罕见的,并且难以诊断. 这一案例表明,分子分析和联合疗法,包括PARP抑制剂,可以有效治疗CDK12突变转移性前列腺癌.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医学遗传学 医学遗传学
背景情况:
- 由前列腺癌引起的阴茎转移是一个不常见的现象.
- 临床表现往往是非特异性的,导致诊断挑战.
研究的目的:
- 报告一个罕见的从前列腺癌引起的阴茎转移病例.
- 突出分子分析和向治疗在治疗晚期前列腺癌中的作用.
主要方法:
- 一名65岁的男性患者患有晚期前列腺癌和阴茎转移.
- 在鉴定了CDK12突变后,治疗涉及雄激素剥夺疗法,胺胺和olaparib (一种PARP抑制剂).
- 诊断工具包括PSA水平,MRI和PSMA PET/CT.
主要成果:
- 患者在66个月的初始治疗中实现了稳定的疾病.
- 阴茎转移被证实并通过手术切除.
- 与olaparib和恩扎胺的联合治疗导致了临床稳定性和低PSA水平.
结论:
- 分子分析,特别是识别CDK12突变,对于引导转移性割抵抗性前列腺癌的治疗至关重要.
- 联合PARP抑制和雄激素受体向疗法显示出对治疗罕见转移的CDK12突变前列腺癌有希望.
相关概念视频
Disorders of the Male Reproductive System
5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K
M-Cdk Drives Transition Into Mitosis
6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K


